Transmyocardial CO2 laser revascularization improves symptoms, function, and quality of life: 12-month results from a randomized controlled trial
- 1 October 2001
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 111 (5) , 341-348
- https://doi.org/10.1016/s0002-9343(01)00878-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparison of Transmyocardial Revascularization with Medical Therapy in Patients with Refractory AnginaNew England Journal of Medicine, 1999
- Transmyocardial Revascularization with a Carbon Dioxide Laser in Patients with End-Stage Coronary Artery DiseaseNew England Journal of Medicine, 1999
- Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trialThe Lancet, 1999
- Current Perspectives on Direct Myocardial RevascularizationThe American Journal of Cardiology, 1998
- Transmyocardial laser revascularization: Results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery diseaseThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Histologic appearance of transmyocardial laser Channels after 41/2 WeeksThe Annals of Thoracic Surgery, 1996
- Does blood flow through holmium: YAG transmyocardial laser channels?The Annals of Thoracic Surgery, 1996
- Development and evaluation of the Seattle Angina questionnaire: A new functional status measure for coronary artery diseaseJournal of the American College of Cardiology, 1995
- Monitoring the quality of life in patients with coronary artery diseaseThe American Journal of Cardiology, 1994
- The MOS Short-form General Health SurveyMedical Care, 1988